# Single-cell RNA-seq uncovers lineage-specific regulatory alterations of fibroblasts and endothelial cells in ligamentum flavum hypertrophy

**Authors:** Yongxin Chen, Jue Zhang, Xincheng Feng, Qinghong Ma, Chao Sun

PMC · DOI: 10.3389/fimmu.2025.1569296 · Frontiers in Immunology · 2025-05-15

## TL;DR

This study uses single-cell RNA sequencing to uncover changes in fibroblasts and endothelial cells in ligamentum flavum hypertrophy, a condition linked to spinal stenosis.

## Contribution

The study identifies five fibroblast subpopulations and key genes in ligamentum flavum hypertrophy using single-cell RNA-seq.

## Key findings

- Five distinct subpopulations of ligamentum flavum fibroblasts are identified, including a mesenchymal subpopulation linked to hypertrophy.
- Key genes like MGP, ASPN, OGN, LUM, and CTSK are highlighted as potential targets for fibrotic disease treatment.
- Endothelial cell heterogeneity is analyzed, emphasizing the role of a specific subpopulation in fibrosis.

## Abstract

Lumbar spinal stenosis (LSS) represents a major global healthcare burden resulting in back pain and disorders of the limbs among the elderly population. The hypertrophy of ligamentum flavum (HLF), marked by fibrosis and inflammation, significantly contributes to LSS. Fibroblasts and endothelial cells are two important cells in the pathological process of ligamentum flavum (LF) fibrosis and inflammation. These two cells exhibit heterogeneity in various fibrotic diseases, yet their heterogeneity in LF fibrosis remains poorly defined.

Using single-cell RNA-seq, we examined the alterations of fibroblasts, endothelial cells, and key genes in the hypertrophic LF, aiming to establish a comprehensive single-cell atlas of LF to identify high-priority targets for pharmaceutical treatment of LSS.

Here, we find there are five distinct subpopulations of LF fibroblasts: secretory-papillary, secretory-reticular, mesenchymal, pro-inflammatory, and unknown. Importantly, in HLF, the proportion of mesenchymal fibroblast subpopulations increases significantly compared to normal LF (NLF), reflecting their close association with the pathogenesis of HLF. Furthermore, critical target genes that might be involved in HLF and fibrosis, such as MGP, ASPN, OGN, LUM, and CTSK, are identified. In addition, we also investigate the heterogeneity of endothelial cells and highlight the critical role of AECs subpopulation in LF fibrosis.

This study will contribute to our understanding of the pathogenesis of HLF and offer possible targets for the treatment of fibrotic diseases.

## Linked entities

- **Genes:** MGP (matrix Gla protein) [NCBI Gene 4256], ASPN (asporin) [NCBI Gene 54829], OGN (osteoglycin) [NCBI Gene 4969], LUM (lumican) [NCBI Gene 4060], CTSK (cathepsin K) [NCBI Gene 1513]
- **Diseases:** lumbar spinal stenosis (MONDO:0005965)

## Full-text entities

- **Genes:** ASPN (asporin) [NCBI Gene 54829] {aka OS3, PLAP-1, PLAP1, SLRR1C}, OGN (osteoglycin) [NCBI Gene 4969] {aka OG, OIF, SLRR3A}, MGP (matrix Gla protein) [NCBI Gene 4256] {aka GIG36, MGLAP, NTI}, CTSK (cathepsin K) [NCBI Gene 1513] {aka CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD}, LUM (lumican) [NCBI Gene 4060] {aka LDC, SLRR2D}
- **Diseases:** fibrosis (MESH:D005355), hypertrophic (MESH:D002312), HLF (MESH:D006984), LF (MESH:D000073872), back pain (MESH:D001416), fibrotic diseases (MESH:D004194), disorders of the limbs (MESH:D001259), LSS (MESH:C563613), inflammation (MESH:D007249)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12119296/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12119296/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12119296/full.md

---
Source: https://tomesphere.com/paper/PMC12119296